Sodium Hyaluronate Specifications: A Guide to COA and Quality Parameters

A Certificate of Analysis (COA) is the single most important document between you and your sodium hyaluronate supplier. It tells you what's actually in the batch — not what was promised, but what was tested and verified. Yet many buyers treat COAs as a formality, glancing at purity and moving on.

That's a mistake. A COA contains 15–25 parameters organized into distinct categories: identity and physical properties, content assay and molecular characterization, purity and impurity profiles, microbiological limits, and stability data. Each parameter tells you something different about the material, and understanding all of them — not just the headline numbers — is what separates confident procurement from costly surprises.

Here's a complete guide to every parameter you'll find on a sodium hyaluronate COA, organized by category, with typical specifications, testing methods, and how different pharmacopoeial standards compare. Whether you're sourcing HA for cosmetics, supplements, ophthalmic solutions, or injectable products, this guide will help you read and evaluate COAs with confidence.

Part I: Identity & Physical Parameters

Before any chemical testing begins, a COA must confirm that the material is actually sodium hyaluronate and meets basic physical requirements.

Appearance: White to almost white powder, granules, or fibrous aggregate. This is a first-line authenticity check — discoloration suggests degradation or contamination.

Identification (IR Spectroscopy): Infrared absorption spectrum must match the reference standard. This is the definitive test for confirming the chemical structure of the sodium hyaluronate polymer — the IR fingerprint of hyaluronic acid is unique, characterized by strong absorption bands at 1610 cm⁻¹ (C=O stretch of carboxylate), 1560 cm⁻¹ (N-H bend of acetamido group), and 1410 cm⁻¹ (C-O stretch). If a COA omits IR identification data, question it.

Identification (Sodium Reaction): The aqueous solution must give a positive sodium ion reaction. This confirms the material is the sodium salt form, not the free acid.

pH (0.5% aqueous solution): Typically 5.0–8.5 across all pharmacopoeias. pH outside this range indicates incomplete purification or degradation.

Appearance of Solution / Transmittance: A 0.5% aqueous solution should be clear with absorbance at 600 nm ≤0.01. High absorbance suggests insoluble particulates or cross-contamination.

Solubility: Sparingly soluble or soluble in water; practically insoluble in acetone and anhydrous ethanol. This confirms the expected solubility behavior.

Bulk Density: Typically 0.1–0.6 g/cm³. While not a quality indicator per se, bulk density matters for powder handling — fill accuracy, mixing uniformity, and dissolution behavior all depend on it.

Particle Size (Mesh): Usually "100% passes 80 mesh" for standard grades. Particle size affects dissolution rate and formulation behavior but is a processing characteristic, not a purity parameter. Finer powders dissolve faster but may clump during handling; coarser powders dissolve more slowly but flow more easily through automated filling equipment.

What these parameters tell you: The identity and physical section of a COA answers three fundamental questions: Is this really sodium hyaluronate? Is it physically intact? Will it behave predictably during processing? If any identity test fails or physical parameters are out of range, the batch should be rejected before any further analysis — because testing a misidentified material wastes time and resources.

[For a deeper understanding of how sodium hyaluronate grades differ in their requirements, read: Sodium Hyaluronate Grades: Food, Cosmetic and Pharmaceutical Grades Explained — [INTERNAL LINK: SH Grades Comparison article]]

Part II: Content Assay & Molecular Characterization

These parameters tell you how much active sodium hyaluronate is in the batch and what its molecular profile looks like.

Sodium Hyaluronate Content (Assay): Typically ≥92.0–95.0% depending on grade. Measured by the glucuronic acid method (carbazole-sulfuric acid colorimetry) or HPLC. The assay converts glucuronic acid content to sodium hyaluronate equivalent using the conversion factor 2.0675 (ratio of the disaccharide unit molecular weight [401.3 Da] to glucuronic acid molecular weight [194.1 Da]). This conversion factor is consistent across pharmacopoeias because it's based on the fundamental chemistry of HA's repeating disaccharide structure.

Glucuronic Acid Content: Typically ≥44.0–45.0%. This is the fundamental building block of the hyaluronic acid chain. A low glucuronic acid reading indicates chain degradation or adulteration with other polysaccharides.

Molecular Weight & Distribution: The most application-critical parameter. COAs should report:

· Weight-average molecular weight (Mw) in kDa or Da

· Molecular weight range (e.g., 50,000–100,000 Da for LMW)

· Polydispersity index (PDI = Mw/Mn), ideally <2.0–3.0

· Analytical method (GPC-MALS is gold standard)

The analytical method matters enormously. Intrinsic viscosity (viscometry) provides only an average value. GPC with MALS detectors gives the full molecular weight distribution. Two suppliers reporting the same "average MW" may have completely different distributions.

Intrinsic Viscosity [η]: Measured by capillary viscometry (Ubbelohde method). Used with the Mark-Houwink-Sakurada equation ([η] = K·M^α) to derive viscosity-average molecular weight (Mv). Reported in dL/g. This is the method referenced in the European Pharmacopoeia. The Mark-Houwink constants differ depending on the MW range: for 500,000–1,490,000 Da, K = 0.00018 and α = 0.65; for 1,500,000–3,900,000 Da, different constants apply. A COA should state which constants were used.

Why molecular characterization matters for hyaluronic acid: The molecular weight and distribution of HA directly determine its biological behavior and physical performance. Two batches with the same average MW but different distributions can perform differently in formulations — one might dissolve cleanly while the other forms gel-like clumps. Always check whether the COA reports Mw, Mn, or Mv, and whether PDI is included.

[For a comprehensive guide to molecular weight science and how to verify COA data, read: Sodium Hyaluronate Molecular Weight: What Buyers Need to Know — [INTERNAL LINK: SH Molecular Weight article]]

[If you're comparing high vs. low molecular weight HA specifically, read: High Molecular Weight vs. Low Molecular Weight Sodium Hyaluronate — [INTERNAL LINK: HMW vs LMW article]]

Part III: Purity & Impurity Parameters

These parameters define what's NOT in your sodium hyaluronate — residual proteins, nucleic acids, heavy metals, solvents, and endotoxins.

Residual Protein: The most closely watched impurity. Limits range from ≤0.1% (cosmetic) to ≤0.05% (pharmaceutical/injection). Tested by Bradford or Lowry method (not UV 280 nm, which overestimates). High protein content indicates incomplete purification and increases allergen risk.

Nucleic Acids: Absorbance at 260 nm ≤0.1–0.5 depending on pharmacopoeia. Residual DNA from the fermentation organism (Streptococcus equi subsp. zooepidemicus) indicates incomplete purification.

Heavy Metals: Total heavy metals (as Pb) ≤10–20 ppm; Arsenic ≤2 ppm. For injection and ophthalmic grades, tighter limits apply. Testing methods include ICP-MS (gold standard, ppb detection limits), ICP-OES, and AAS.

Residual Solvents: Methanol and ethanol are the most common — used in precipitation-based purification. Limits vary by pharmacopoeia but are typically methanol ≤0.05% and ethanol ≤0.5%. Tested by headspace gas chromatography.

Bacterial Endotoxin: Critical for injectable and ophthalmic applications. Limits range from ≤0.5 EU/mg (ophthalmic) to ≤0.05 EU/mg (injection). Tested by LAL (Limulus Amebocyte Lysate) assay. Cosmetic and food grades may not require endotoxin testing, but sophisticated buyers increasingly request it as a quality indicator.

Chlorides: ≤0.5%. Tests for residual chloride ions from processing.

Iron: ≤80 ppm (per European Pharmacopoeia). Tested by atomic absorption spectrometry.

Residue on Ignition: ≤13–20%. Measures total inorganic content after combustion. A high value indicates excessive mineral salt carryover from the fermentation or purification process.

What these parameters collectively reveal: The impurity profile of a sodium hyaluronate batch tells you about the effectiveness of the purification process. Well-controlled manufacturing yields low, consistent protein and nucleic acid levels. Spikes in these values across batches suggest inconsistent purification. For any application involving injection or ophthalmic use, endotoxin data is non-negotiable.

[For a complete guide to purity testing methods and how to interpret COA impurity data, read: Sodium Hyaluronate Purity: What Does It Mean and How Is It Tested? — [INTERNAL LINK: SH Purity article]]

Part IV: Microbiological Parameters

Microbial limits ensure the material is safe for its intended route of exposure.

Total Aerobic Microbial Count (TAMC): ≤100 CFU/g for cosmetic grade; ≤10 CFU/g for pharmaceutical grade. Tested by pour plate or membrane filtration method.

Total Yeast and Mold Count (TYMC): ≤50–100 CFU/g. Yeast and mold contamination indicates poor storage or packaging conditions.

Specified Microorganisms (all must be negative):

· Staphylococcus aureus (per gram)

· Pseudomonas aeruginosa (per gram)

· Escherichia coli (per gram)

· Salmonella (per 25 g, for food grade)

These are absence tests — any detection is a failure. Their inclusion reflects the risk profile of each route: topical products need pathogen absence, injectable products need near-sterile conditions.

Why microbiological limits vary by application: The difference between cosmetic-grade and pharmaceutical-grade microbial limits isn't arbitrary — it reflects real contamination risk. A serum applied to intact skin carries far lower infection risk than a joint injection that bypasses the body's natural barriers.

Sterility vs. Bioburden: Note that standard COAs report bioburden limits (microbial counts), not sterility. Sterility testing (direct inoculation or membrane filtration per pharmacopoeia) is required separately for products labeled "sterile." Most raw material COAs report bioburden; if you need sterility assurance, confirm with your supplier that sterility testing is included.

Part V: Stability, Packaging & Labeling

The final section of a COA addresses how the material should be stored, how long it remains stable, and what documentation accompanies it.

Loss on Drying (LOD): ≤8–15% depending on pharmacopoeia. Measured by vacuum drying over P₂O₅ or at 100–110°C. Sodium hyaluronate is highly hygroscopic — excessive moisture accelerates molecular weight degradation and microbial growth.

Stability & Shelf Life: Typically 24–36 months unopened, stored at 2–8°C in cool, dry conditions in original sealed packaging. Some manufacturers specify room temperature storage if the packaging (triple-layer aluminum foil bags with desiccant) provides adequate moisture protection. HA is sensitive to hydrolytic degradation — moisture and heat break the glycosidic bonds in the polymer chain, reducing molecular weight over time.

Packaging: Standard packaging is polyethylene inner bag + triple-layer aluminum foil outer bag. Size varies from 1 kg to 25 kg depending on order volume. For pharmaceutical and injection grades, packaging materials should meet extractables and leachables requirements.

Labeling Requirements (per European Pharmacopoeia):

· Intrinsic viscosity value

· Origin of the substance (fermentation vs. extraction)

· Intended use (cosmetic, pharmaceutical, parenteral, intra-articular, intra-ocular)

· Batch number and expiry date

· Storage conditions

Global Pharmacopoeia Comparison: Key Parameters at a Glance

Different pharmacopoeias set different standards for the same material. Here's how the major ones compare:

Key insight: The Chinese Pharmacopoeia is the most prescriptive about molecular weight specifications — it defines specific MW ranges for different applications. The European Pharmacopoeia focuses more on intrinsic viscosity as a proxy for HA molecular weight. The USP is less specific about MW but stricter on protein limits for parenteral use. Understanding these differences is essential when sourcing for different markets.

Also note that food-grade HA is governed by food additive specifications rather than pharmacopoeias. In China, the Standards of Food Additives specify different limits; in the US, food-grade HA follows GRAS notification requirements rather than USP monographs.

[For a detailed comparison of grade-specific requirements, read: Sodium Hyaluronate Grades: Food, Cosmetic and Pharmaceutical Grades Explained — [INTERNAL LINK: SH Grades Comparison article]]

How to Read a COA: A Step-by-Step Walkthrough

When you receive a COA from a supplier, here's the systematic approach to evaluating it:

Step 1: Verify identity first. Check that IR identification and sodium reaction are both reported as "Complies." If these are missing or "Not Tested," stop — you can't proceed without confirming the material is what it claims to be.

Step 2: Check the assay. Confirm sodium hyaluronate content matches the grade you ordered. A cosmetic-grade supplier claiming ≥98% is unusual and worth questioning — verify whether they're reporting total solids or actual SH content.

Step 3: Confirm molecular weight match. Compare the reported MW (and method) against your specification. Check whether PDI is reported. If only "average MW" is stated without method or distribution, request the full GPC chromatogram.

Step 4: Scan impurity parameters. Protein, nucleic acids, heavy metals, residual solvents, endotoxin — compare each against your application's requirements and relevant pharmacopoeia.

Step 5: Check microbiological results. Confirm all specified microorganisms tested negative and that microbial counts are within limits for your grade.

Step 6: Verify storage and expiry. Confirm the material's remaining shelf life when it arrives. LOD should be within limits.

Step 7: Cross-reference with pharmacopoeia. If your product will be registered in a regulated market, compare the COA values against the relevant pharmacopoeia monograph requirements.

Step 8: Look for red flags. Common COA red flags include parameters reported as "Not Tested," assay values that seem too perfect, molecular weight reported without analytical method, missing lot-specific data, and inconsistent dates. These suggest incomplete quality control or a supplier who doesn't prioritize documentation rigor.

Shandong Runxin Biotechnology provides fully transparent, parameter-complete COAs for every batch of sodium hyaluronate we supply. Our analytical platform includes GPC-MALS for full molecular weight distribution profiling, Bradford protein quantification (LOQ 0.005%), LAL endotoxin testing, ICP-MS heavy metal screening, and headspace GC for residual solvents. Every parameter is reported with its test method, detection limit, and acceptance criteria — giving you everything needed for pharmacopoeia compliance and regulatory submission. With 28 years of fermentation expertise and certifications spanning ISO 13485, CE, DMF 036368, COSMOS, HALAL, and cGMP, we understand that a COA isn't just a document — it's the foundation of trust between supplier and buyer.

Need help interpreting a COA or establishing specifications for your application? Contact Runxin Biotechnology with your target market and product type — we'll provide a sample COA and help you define the parameters that matter for your specific use case.